187 related articles for article (PubMed ID: 19909340)
1. Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2.
Nakagawa H; Wakabayashi-Nakao K; Tamura A; Toyoda Y; Koshiba S; Ishikawa T
FEBS J; 2009 Dec; 276(24):7237-52. PubMed ID: 19909340
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.
Nakagawa H; Tamura A; Wakabayashi K; Hoshijima K; Komada M; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
Biochem J; 2008 May; 411(3):623-31. PubMed ID: 18237272
[TBL] [Abstract][Full Text] [Related]
3. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.
Furukawa T; Wakabayashi K; Tamura A; Nakagawa H; Morishima Y; Osawa Y; Ishikawa T
Pharm Res; 2009 Feb; 26(2):469-79. PubMed ID: 18958403
[TBL] [Abstract][Full Text] [Related]
4. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.
Diop NK; Hrycyna CA
Biochemistry; 2005 Apr; 44(14):5420-9. PubMed ID: 15807535
[TBL] [Abstract][Full Text] [Related]
5. Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.
Wakabayashi K; Nakagawa H; Tamura A; Koshiba S; Hoshijima K; Komada M; Ishikawa T
J Biol Chem; 2007 Sep; 282(38):27841-6. PubMed ID: 17686774
[TBL] [Abstract][Full Text] [Related]
6. Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation.
Wakabayashi-Nakao K; Tamura A; Furukawa T; Nakagawa H; Ishikawa T
Adv Drug Deliv Rev; 2009 Jan; 61(1):66-72. PubMed ID: 19111842
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.
Polgar O; Ierano C; Tamaki A; Stanley B; Ward Y; Xia D; Tarasova N; Robey RW; Bates SE
Biochemistry; 2010 Mar; 49(10):2235-45. PubMed ID: 20088606
[TBL] [Abstract][Full Text] [Related]
8. N-glycosylation of human sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is essential for stability, secretion and activity.
Traini M; Kumaran R; Thaysen-Andersen M; Kockx M; Jessup W; Kritharides L
Biochem J; 2017 Mar; 474(7):1071-1092. PubMed ID: 28104755
[TBL] [Abstract][Full Text] [Related]
9. Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells.
Mochizuki K; Kagawa T; Numari A; Harris MJ; Itoh J; Watanabe N; Mine T; Arias IM
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G818-28. PubMed ID: 17082223
[TBL] [Abstract][Full Text] [Related]
10. Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system.
Wakabayashi K; Nakagawa H; Adachi T; Kii I; Kobatake E; Kudo A; Ishikawa T
J Exp Ther Oncol; 2006; 5(3):205-22. PubMed ID: 16528971
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
[TBL] [Abstract][Full Text] [Related]
12. Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.
Polgar O; Ozvegy-Laczka C; Robey RW; Morisaki K; Okada M; Tamaki A; Koblos G; Elkind NB; Ward Y; Dean M; Sarkadi B; Bates SE
Biochemistry; 2006 Apr; 45(16):5251-60. PubMed ID: 16618113
[TBL] [Abstract][Full Text] [Related]
13. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
Henriksen U; Gether U; Litman T
J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
[TBL] [Abstract][Full Text] [Related]
14. Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3.
Beers MF; Zhao M; Tomer Y; Russo SJ; Zhang P; Gonzales LW; Guttentag SH; Mulugeta S
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L970-80. PubMed ID: 24142515
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.
Tamura A; Wakabayashi K; Onishi Y; Takeda M; Ikegami Y; Sawada S; Tsuji M; Matsuda Y; Ishikawa T
Cancer Sci; 2007 Feb; 98(2):231-9. PubMed ID: 17297656
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1.
Sugiyama T; Shuto T; Suzuki S; Sato T; Koga T; Suico MA; Kusuhara H; Sugiyama Y; Cyr DM; Kai H
Biochem Biophys Res Commun; 2011 Jan; 404(3):853-8. PubMed ID: 21184741
[TBL] [Abstract][Full Text] [Related]
17. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
18. Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2).
Mohrmann K; van Eijndhoven MA; Schinkel AH; Schellens JH
Cancer Chemother Pharmacol; 2005 Oct; 56(4):344-50. PubMed ID: 15875186
[TBL] [Abstract][Full Text] [Related]
19. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.
Litman T; Jensen U; Hansen A; Covitz KM; Zhan Z; Fetsch P; Abati A; Hansen PR; Horn T; Skovsgaard T; Bates SE
Biochim Biophys Acta; 2002 Sep; 1565(1):6-16. PubMed ID: 12225847
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
